ENBIO Co., Ltd. (KOSDAQ:352940)
South Korea · Delayed Price · Currency is KRW 2,025.00
-55.00 (-2.64%)
At close: Aug 24, 2026
ENBIO Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 36,183 | 33,953 | 35,654 | 34,024 | 34,240 | 33,466 |
Other Revenue | -0 | -0 | -0 | -0 | - | - |
| 36,183 | 33,953 | 35,654 | 34,024 | 34,240 | 33,466 | |
Revenue Growth | 7.81% | -4.77% | 4.79% | -0.63% | 2.31% | -3.17% |
Cost of Revenue | 22,292 | 22,354 | 24,081 | 26,970 | 27,898 | 22,713 |
Gross Profit | 13,891 | 11,599 | 11,573 | 7,055 | 6,342 | 10,753 |
Selling, General & Admin | 10,585 | 8,768 | 8,864 | 9,052 | 8,859 | 7,562 |
Research & Development | 801.26 | 801.26 | 660.76 | 578.48 | 523.54 | 387.91 |
Amortization of Goodwill & Intangibles | 12.57 | 12.57 | 16.16 | 17.23 | 1,064 | 1,123 |
Other Operating Expenses | 60.04 | 60.04 | 55.73 | 44.43 | 46.41 | 45.36 |
Operating Expenses | 12,660 | 10,682 | 10,194 | 10,408 | 11,119 | 9,631 |
Operating Income | 1,230 | 917.42 | 1,378 | -3,354 | -4,777 | 1,122 |
Interest Expense | -608.66 | -608.66 | -651.99 | -2,449 | -2,104 | -818.65 |
Interest & Investment Income | 61.83 | 66.11 | 86.74 | 347.08 | 256.72 | 96.61 |
Currency Exchange Gain (Loss) | 112.25 | 112.25 | -416.21 | -275.74 | - | -169.27 |
Other Non Operating Income (Expenses) | -852.26 | 5.46 | 90.88 | 380.31 | 2,793 | 6,158 |
EBT Excluding Unusual Items | -56.4 | 492.57 | 487.55 | -5,351 | -3,832 | 6,389 |
Gain (Loss) on Sale of Investments | 329.49 | 329.49 | 271.47 | 1.67 | - | - |
Gain (Loss) on Sale of Assets | 540.97 | 540.97 | 419.04 | 25.32 | - | 141.07 |
Asset Writedown | -162.43 | -162.43 | -293.42 | -1,273 | - | -401.93 |
Other Unusual Items | - | - | - | -1,463 | - | - |
Pretax Income | 651.63 | 1,201 | 884.64 | -8,060 | -3,832 | 6,128 |
Income Tax Expense | 77.11 | 193.3 | 239.02 | -1,760 | -387.14 | 882.84 |
Net Income | 574.52 | 1,007 | 645.61 | -6,300 | -3,445 | 5,245 |
Net Income to Common | 574.52 | 1,007 | 645.61 | -6,300 | -3,445 | 5,245 |
Net Income Growth | 305.71% | 56.02% | - | - | - | - |
Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | 11 |
Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 11 | 11 |
Shares Change | 9.43% | -0.68% | 0.74% | -0.04% | -3.41% | 36.03% |
EPS (Basic) | 52.84 | 92.69 | 59.00 | -580.00 | -317.00 | 492.55 |
EPS (Diluted) | 52.84 | 92.69 | 59.00 | -580.00 | -317.00 | 344.00 |
EPS Growth | 270.73% | 57.10% | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -5,730 | 2,267 | -3,763 | 10,766 | -8,679 | -5,205 |
Free Cash Flow Per Share | -527.05 | 208.58 | -343.93 | 991.10 | -798.65 | -462.61 |
Gross Margin | 38.39% | 34.16% | 32.46% | 20.73% | 18.52% | 32.13% |
Operating Margin | 3.40% | 2.70% | 3.86% | -9.86% | -13.95% | 3.35% |
Profit Margin | 1.59% | 2.97% | 1.81% | -18.52% | -10.06% | 15.67% |
Free Cash Flow Margin | -15.84% | 6.68% | -10.55% | 31.64% | -25.35% | -15.55% |
EBITDA | 2,880 | 2,563 | 3,157 | -746.91 | -2,538 | 3,411 |
EBITDA Margin | 7.96% | 7.55% | 8.86% | -2.20% | -7.41% | 10.19% |
D&A For EBITDA | 1,649 | 1,646 | 1,779 | 2,607 | 2,239 | 2,289 |
EBIT | 1,230 | 917.42 | 1,378 | -3,354 | -4,777 | 1,122 |
EBIT Margin | 3.40% | 2.70% | 3.86% | -9.86% | -13.95% | 3.35% |
Effective Tax Rate | 11.83% | 16.10% | 27.02% | - | - | 14.41% |
Advertising Expenses | - | 9.59 | 59.38 | 268.31 | 271.48 | 197.66 |